Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Weber

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Vaccine: X|August 14, 2023
Analyzing factors determining vaccination willingness against COVID-19 in Germany 2020Caroline Dotter, Sonja Haug, Rainer Schnell, et al.
Fortschritte Der Neurologie-Psychiatrie|December 19, 2023
[Pacemaker, organ or walking stick? Pre-op association with and post-op subjective perception of a deep brain stimulation device]Henriette Krug, Anna Scharf, Karsten Weber, et al.
Science and Engineering Ethics|September 14, 2017
Methods for Practising Ethics in Research and Innovation: A Literature Review, Critical Analysis and RecommendationsWessel Reijers, David Wright, Philip Brey, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2022
[Capable or incapable of giving consent? Assessing a patient's capacity to consent: Procedures and challenges in daily clinical practice]Henriette Krug, Helene Gerhards, Uta Bittner, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 18, 2011
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancerBerit Maria Müller, Ralf Kronenwett, Guido Hennig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" TrialSabine Riethdorf, Volkmar Müller, Sibylle Loibl, et al.
British Journal of Cancer|November 16, 2019
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trialIsabell Witzel, Sibylle Loibl, Ralph Wirtz, et al.
BMC Medicine|October 11, 2018
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trialInes Stevic, Volkmar Müller, Karsten Weber, et al.
MMW Fortschritte Der Medizin|August 12, 2021
[The G-BA innovation fund's project "Avenue-Pal" - analysis and improvement of cross-sectoral and cross-departmental interface and relocation management in palliative care]Wolfgang George, Petra Steffen, Karl Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular PredictorSibylle Loibl, Karsten Weber, Jens Huober, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Vaccine: X|August 14, 2023
Analyzing factors determining vaccination willingness against COVID-19 in Germany 2020Caroline Dotter, Sonja Haug, Rainer Schnell, et al.
Fortschritte Der Neurologie-Psychiatrie|December 19, 2023
[Pacemaker, organ or walking stick? Pre-op association with and post-op subjective perception of a deep brain stimulation device]Henriette Krug, Anna Scharf, Karsten Weber, et al.
Science and Engineering Ethics|September 14, 2017
Methods for Practising Ethics in Research and Innovation: A Literature Review, Critical Analysis and RecommendationsWessel Reijers, David Wright, Philip Brey, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2022
[Capable or incapable of giving consent? Assessing a patient's capacity to consent: Procedures and challenges in daily clinical practice]Henriette Krug, Helene Gerhards, Uta Bittner, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 18, 2011
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancerBerit Maria Müller, Ralf Kronenwett, Guido Hennig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" TrialSabine Riethdorf, Volkmar Müller, Sibylle Loibl, et al.
British Journal of Cancer|November 16, 2019
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trialIsabell Witzel, Sibylle Loibl, Ralph Wirtz, et al.
BMC Medicine|October 11, 2018
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trialInes Stevic, Volkmar Müller, Karsten Weber, et al.
MMW Fortschritte Der Medizin|August 12, 2021
[The G-BA innovation fund's project "Avenue-Pal" - analysis and improvement of cross-sectoral and cross-departmental interface and relocation management in palliative care]Wolfgang George, Petra Steffen, Karl Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular PredictorSibylle Loibl, Karsten Weber, Jens Huober, et al.
Pageof 4